NASDAQ:RNA | Cash Flow Statement | Atrium Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$20.19M
2026-03-31-$16.63M-$31.14M$2.1M-$2.1M$301.51M
2025-06-30-$12.88M
2025-03-31-$7.45M-$11.1M$0.00$0.00$11.1M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.